The Hippo pathway and human cancerKieran F. Harvey(Peter MacCallum Cancer Centre), Xiaomeng Zhang(University of Melbourne), David M. Thomas(University of Melbourne)Nature reviews. CancerMarch 7, 201310.1038/nrc3458Cited by 1,885SaveCiteExport RISWatch citationsAbstractRelated PapersE-cadherin germline mutations in familial gastric cancerParry Guilford, Justin Hopkins, James Harraway et al.|Nature|1998|1.7kDiverse somatic mutation patterns and pathway alterations in human cancersZhengyan Kan, Bijay S. Jaiswal, Jeremy Stinson et al.|Nature|2010|1kMst1 and Mst2 Maintain Hepatocyte Quiescence and Suppress Hepatocellular Carcinoma Development through Inactivation of the Yap1 OncogeneDawang Zhou, Claudius Conrad, Fan Xia et al.|Cancer Cell|2009|935Identifying tumor suppressors in genetic mosaics: the <i>Drosophila lats</i> gene encodes a putative protein kinaseTian Xu, Weiyi Wang, Sheng Zhang et al.|Development|1995|792Anoikis resistance and tumor metastasisCraig D. Simpson, Kika Anyiwe, Aaron D. Schimmer|Cancer Letters|2008|642